By combining our present findings on SENP1 and MEF2C deSUMOylation in protecting against ICM, it is highly likely that the modulation of the SUMO system for a selective transcription factor within cardiomyocytes is critical in the pathogenesis of cardiac disease. The gene discussed is MEF2C; the disease is heart disorder.